|
1
|
BVF Inc
San Francisco,
California
|
$15.9M
|
+$13.3M
|
+5,050,000
|
+137%
|
|
|
2
|
Bellevue Group
Kuesnacht,
Switzerland
|
$10.7M
|
+$2.34M
|
+888,869
|
+18%
|
|
|
3
|
Soleus Capital Management
Greenwich,
Connecticut
|
$4.81M
|
-$4.03M
|
-1,528,260
|
-37%
|
|
|
4
|
Avidity Partners Management
Dallas,
Texas
|
$4.48M
|
–
|
–
|
–
|
|
|
5
|
|
$3.83M
|
-$4.12M
|
-1,563,661
|
-43%
|
|
|
6
|
Eventide Asset Management
Boston,
Massachusetts
|
$2.84M
|
-$4.75M
|
-1,804,317
|
-54%
|
|
|
7
|
PFM Health Sciences
San Francisco,
California
|
$2.69M
|
+$1.36M
|
+516,536
|
+54%
|
|
|
8
|
|
$2.39M
|
-$3.49M
|
-1,325,898
|
-50%
|
|
|
9
|
Adage Capital Partners
Boston,
Massachusetts
|
$1.9M
|
–
|
–
|
–
|
|
|
10
|
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
$1.35M
|
–
|
–
|
–
|
|
|
11
|
Frazier Life Sciences Management
Palo Alto,
California
|
$1.26M
|
–
|
–
|
–
|
|
|
12
|
|
$1.17M
|
+$1.69M
|
+640,645
|
New
|
|
|
13
|
Rock Springs Capital Management
Baltimore,
Maryland
|
$955K
|
–
|
–
|
–
|
|
|
14
|
|
$910K
|
+$420K
|
+159,207
|
+47%
|
|
|
15
|
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$760K
|
-$395K
|
-149,811
|
-26%
|
|
|
16
|
Millennium Management
New York
|
$740K
|
+$211K
|
+80,031
|
+24%
|
|
|
17
|
MPM BioImpact
Boston,
Massachusetts
|
$738K
|
-$672K
|
-255,192
|
-39%
|
|
|
18
|
Woodline Partners
San Francisco,
California
|
$696K
|
+$1.01M
|
+382,282
|
New
|
|
|
19
|
Two Sigma Investments
New York
|
$633K
|
+$781K
|
+296,302
|
+576%
|
|
|
20
|
Two Sigma Advisers
New York
|
$623K
|
+$768K
|
+291,300
|
+570%
|
|
|
21
|
Omega Fund Management
Boston,
Massachusetts
|
$597K
|
–
|
–
|
–
|
|
|
22
|
|
$432K
|
+$350K
|
+132,760
|
+127%
|
|
|
23
|
Renaissance Technologies
New York
|
$338K
|
+$422K
|
+160,310
|
+626%
|
|
|
24
|
Marshall Wace
London,
United Kingdom
|
$209K
|
+$247K
|
+93,729
|
+438%
|
|
|
25
|
CIBC World Market
Toronto,
Ontario, Canada
|
$141K
|
-$45.7K
|
-17,342
|
-18%
|
|
